Free Daily Podcast Summary
JAMA Clinical Reviews: Daily Summaries Delivered
by JAMA Network
Author interviews that explore the latest clinical reviews.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 3 days ago16 min
Idiosyncratic Drug-Induced Liver Injury: Diagnosis, Risk Factors, and Management
Idiosyncratic drug-induced liver injury is damage caused by prescription or over-the-counter medications or herbal dietary supplements that is not dose-dependent. JAMA Associate Editor Beverly Forsyth, MD, speaks with author Naga Chalasani, MD, of Indiana University School of Medicine about risk factors, evaluation, and treatment of patients with idiosyncratic drug-induced liver injury. Related Content: Idiosyncratic Drug-Induced Liver Injury Severe Acute Liver Injury After Hepatotoxic Medication Initiation in Real-World Data
- 2 weeks ago17 min
Diagnosis and Management of Childhood Obesity
Childhood obesity affects approximately 15% of children aged 2 to 12 and is associated with adverse health outcomes in adulthood. Author Claudia K. Fox, MD, MPH, of the University of Minnesota Medical School joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss epidemiology, diagnosis, and treatment of childhood obesity. Related Content: Obesity in Children Aged 2 to 12 Years
- 3 weeks ago22 min
Heart Transplant for Advanced Heart Failure
Heart transplant for patients with advanced heart failure can lead to improved survival and quality of life. Author JoAnne Lindenfeld, MD, of Vanderbilt University joins JAMA Associate Editor David Simel, MD, MHS, to discuss indications, transplant evaluation, management after transplant, long-term complications, and survival. Related Content: Heart Transplant for Advanced Heart Failure
- Oct 5, 202620 min
Narcolepsy: A Review
Narcolepsy is a chronic neurologic disorder that causes severe daytime sleepiness and impaired quality of life. Author Tom Scammell, MD, of Harvard Medical School joins JAMA Deputy Editor Karen Lasser, MD, MPH, to discuss the etiology, clinical presentation, diagnostic evaluation, and treatment of narcolepsy. Related Content: Narcolepsy The Orexin System—A Key Component of Sleep Regulatory Networks and Involvement in Narcolepsy
- Sep 30, 202614 min
Influenza, RSV, and COVID-19 Vaccines: Effectiveness, Safety, and Trust in 2026
Respiratory virus vaccine effectiveness and safety for influenza, RSV, and COVID-19 are reviewed, including new evidence, risks, and recommendations. JAMA Deputy Editor Preeti Malani, MD, MSJ, speaks with Rochelle Walensky, MD, MPH, professor of medicine at Harvard Medical School and former CDC Director, about vaccine data, public trust, and the 2026 respiratory virus season. Related Content: Respiratory Season Virus Vaccines RSV Immunization Effectiveness and Safety for the 2026-2027 Respiratory Season Influenza Vaccine Effectiveness and Safety for the 2026-2027 Respiratory Season COVID-19 Vaccine Effectiveness and Safety for the 2026-2027 Respiratory Season
- Sep 21, 202620 min
Vaccines for Cancer Treatment
Cancer vaccines stimulate immune cells to recognize proteins or mutations found on or within cancer cells, facilitating destruction of cancer cells. Several vaccines are approved and others are in development for cancer treatment. Author Nora Disis, MD, JAMA Deputy Editor and Editor in Chief of JAMA Oncology, discusses cancer vaccines and more with JAMA Deputy Editor Mary McDermott, MD. Related Content: Vaccines for Cancer
- Sep 14, 202619 min
Idiopathic Normal Pressure Hydrocephalus: Diagnosis and Treatment
Idiopathic normal pressure hydrocephalus (iNPH) affects approximately 1% to 4% of adults aged 65 years and older and is associated with gait impairment, cognitive decline, and urinary dysfunction. Author Mark G. Luciano, MD, PhD, from Johns Hopkins University, discusses this and more with JAMA Deputy Editor Kristin Walter, MD, MS. Related Content: Idiopathic Normal Pressure Hydrocephalus
- Sep 10, 202623 min
Rheumatoid Arthritis
Rheumatoid arthritis can affect any synovial joint and cause irreversible damage, but early diagnosis and treatment with DMARDs can reduce inflammation and lower the risk of joint destruction. JAMA Associate Editor David Simel, MD, MHS, is joined by review coauthor Josef Smolen, MD, to discuss this topic. Related Content: Rheumatoid Arthritis in Adults
Get JAMA Clinical Reviews summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
Health vs Hype with the American Medical Association
A medical expert debunks viral health trends and misinformation with science-backed insights from physicians.
The Curbsiders Internal Medicine Podcast
Expert-led internal medicine discussions with clinical insights and humor for primary care and hospital medicine providers.
Health Discovered
Doctors explore surprising stories to uncover insights about health and well-being.
In the Interim...
Explores Bayesian statistics and adaptive clinical trial designs in medical research with insights from industry experts.
The Peter Attia Drive
Conversations with experts on health, longevity, performance, and critical thinking led by physician Peter Attia.
Unbiased Science
Dr. Jess Steier and guests analyze viral health claims using scientific evidence and explain key findings for everyday conversations.
ICU Ed and Todd-Cast
Eddie and Todd
Red Pill Your Healthcast
Two healthcare providers discuss overlooked health issues and empower listeners to make informed decisions for their families.
This Week in Cardiology
A weekly summary and analysis of key developments in cardiology for healthcare professionals.
JOSPT Insights
JOSPT
Frankly Speaking About Family Medicine
Discusses current topics and developments in primary care and family medicine.
Get Better Faster
Doctors and researchers discuss functional medicine and root-cause approaches to chronic illness and health optimization.
About JAMA Clinical Reviews
Author interviews that explore the latest clinical reviews.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from JAMA Clinical Reviews in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's JAMA Clinical Reviews daily summary?
It's a free AI-powered email that summarizes new episodes of JAMA Clinical Reviews as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the JAMA Clinical Reviews podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official JAMA Clinical Reviews product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by JAMA Network.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
How often does JAMA Clinical Reviews release new episodes?
JAMA Clinical Reviews publishes weekly. Our AI generates a summary within hours of each new episode.
What topics does JAMA Clinical Reviews cover?
JAMA Clinical Reviews covers topics including Science, Medicine, Fitness, Health & Fitness. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting JAMA Clinical Reviews summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.